BioCentury
ARTICLE | Finance

Arch's golden returns

Tallying Arch Venture's wins from Agios and Receptos

June 29, 2015 7:00 AM UTC

Mid-month SEC filings show Arch Venture Partners has used two companies with roaring stock prices - Agios Pharmaceuticals Inc. (NASDAQ:AGIO) and Receptos Inc. (NASDAQ:RCPT) - to completely pay back LPs in its $400 million seventh fund. A potentially even bigger Fund VII winner is waiting in the wings in Juno Therapeutics Inc. (NASDAQ:JUNO).

Agios and Receptos are the firm's two largest wins in terms of absolute returns. Arch has distributed $214.4 million in Agios stock and $210.2 million of Receptos stock to LPs over the past year...